openPR Logo

Press Releases from Janus Kinase (JAK) Inhibitors - Pharma Proff (1 total)

Janus Kinase (JAK) Inhibitors Pipeline to Witness Significant Growth due to Posi …

JAK comprises four receptors JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2) which help in cytokine mediated signaling through the JAK/STAT pathway. There are two nearly identical phosphate transferring domains present in JAKs. The first domain demonstrates kinase activity while the other regulates the activity of the first via negative inhibition. The mutations in the JAK/STAT pathway leads to different medical conditions. Download the sample report: https://www.pharmaproff.com/request-sample/1216 The JAK inhibitors work by

Go To Page:   1 2 3 4 5 6 7 8 9 10